| Analysis | Metabolite Name | Measured Value | Units | Construct |
|---|---|---|---|---|
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 1178 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 2071 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 2256 | Peak area | Control lentivirus |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 2884 | Peak area | Control lentivirus |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | 3020 | Peak area | Noxa knockdown |
| Reversed phase NEGATIVE ION MODE | CITRULLINE (CAS# 372-75-8); (M-H)- | Peak area | Control lentivirus |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|